LeaderPortfolio
Maag
Rudolf Maag
Rank #556
SWITZERLANDHealthcareMedical devices

Rudolf Maag

Net Worth
$6.956B
+1.68% (24h)
Rudolf Maag, a Swiss entrepreneur, has built a significant fortune in the medical device industry. Born in 1946, Maag is 80 years old as of March 2026. He earned an MBA from INSEAD in 1973, which helped launch his career. He is known for his strategic vision and leadership in the healthcare sector. Maag's estimated net worth is $6.26 billion, primarily derived from his investments in medical devices and related ventures. He has a Master of Business Administration from INSEAD.

How to read Rudolf Maag's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Rudolf Maag, we anchor the narrative to Medical devices and Medical devices, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $6.956B alongside global rank #556, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (SWITZERLAND) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Rudolf Maag was born in Liestal, Switzerland, in 1946. His early life was relatively private, but he displayed a keen intellect and drive to excel.

Rise to Success

Maag's career began in 1968 at the Basler Handelsgesellschaft (UTC). In 1973, he joined Sandoz AG, a pharmaceutical company, where he held leadership positions. He transitioned to Straumann, a dental company, where he saw potential in the medical device division. In 1990, he bought the division, creating Stratec Medical. Stratec went public in 1996. In 1999, he merged Stratec with Synthes, building a 15% stake. Johnson & Johnson acquired Synthes-Stratec in 2012.

Key Business Strategies

Maag's success stems from his strategic decisions and understanding of the medical device market. He acquired Straumann's medical device division, recognizing its growth potential. His focus on innovation and business development played a key role in his achievements. He also served as chairman of the board of Straumann Holdings from 2002-2010.

Philanthropy

Maag is involved in philanthropy, having made a significant contribution to INSEAD, where he earned his MBA, marking him as the institution's largest donor.

Career Timeline

2002-2010

Chairman of the Board

Served as chairman of the board of Straumann Holdings.

1999

Merged Stratec with Synthes

Merged Stratec with Synthes and built a 15% stake.

1990

Founded Stratec Medical

Bought the medical device division of Straumann and created Stratec Medical.

1973

Earned MBA

Earned an MBA from INSEAD.

Philanthropic Impact

Education$5.9M

INSEAD Donation

Made a significant contribution to INSEAD, making him the institution's largest donor.

Key Business Ventures & Holdings

CompanyStakeValue
Straumann Holding12.00%

Net Worth History

In-Depth Analysis

Early Life

Rudolf Maag was born in Liestal, Switzerland, in 1946. His early life was relatively private, but he displayed a keen intellect and drive to excel.

Rise to Success

Maag's career began in 1968 at the Basler Handelsgesellschaft (UTC). In 1973, he joined Sandoz AG, a pharmaceutical company, where he held leadership positions. He transitioned to Straumann, a dental company, where he saw potential in the medical device division. In 1990, he bought the division, creating Stratec Medical. Stratec went public in 1996. In 1999, he merged Stratec with Synthes, building a 15% stake. Johnson & Johnson acquired Synthes-Stratec in 2012.

Key Business Strategies

Maag's success stems from his strategic decisions and understanding of the medical device market. He acquired Straumann's medical device division, recognizing its growth potential. His focus on innovation and business development played a key role in his achievements. He also served as chairman of the board of Straumann Holdings from 2002-2010.

Philanthropy

Maag is involved in philanthropy, having made a significant contribution to INSEAD, where he earned his MBA, marking him as the institution's largest donor.

Data Sources & Methodology

Figures for Rudolf Maag are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.